Internationally, psychiatric work capacity assessments increasingly emphasise functioning, participation, contextual factors, and return-to-work processes rather than diagnosis alone. Nevertheless, substantial inter-rater variability persists in routine clinical practice, particularly in short-term sickness benefit evaluations, in which clinicians must balance therapeutic protection, proportionality, prevention of chronicity, and occupational reintegration.
Since 2015, Swiss Federal Supreme Court case law has progressively established a structured medico-legal framework for evaluating psychiatric disorders, initially for persistent somatoform pain disorders and subsequently for depressive and substance-related disorders. These principles were mainly developed for disability insurance and long-term invalidity assessments. However, their direct application to sickness benefit insurance may be clinically problematic because such evaluations involve shorter time horizons, different objectives, and a preventive dimension.
Drawing on fifteen years of structured intervision among independent psychiatrists engaged in ongoing clinical practice, this Viewpoint presents a pragmatic clinical synthesis of dimensions that have already been described separately in the international peer-reviewed literature on psychiatric work capacity assessment. The framework integrates symptom severity, functional impairment, contextual stressors, and longitudinal coherence into a simplified four-level model intended to facilitate communication among general practitioners, psychiatrists, employers, insurers, and medical advisors.
Severity level 0 corresponds to situations with no clinically relevant psychiatric disorder or objective functional impairment. Severity level 1 includes mild but clinically meaningful conditions in which temporary preventive sick leave may support stabilisation and recovery. Severity level 2 encompasses moderate disorders associated with clear functional repercussions that may require time-limited incapacity and regular reassessment. Severity level 3 refers to severe psychiatric disorders associated with marked and pervasive impairment that may require prolonged support and multidisciplinary coordination.
The originality of this framework lies not in the creation of new validated constructs, but in the synthesis and simplified visual operationalisation of function-oriented and biopsychosocial dimensions already recognised internationally, including functioning-based and return-to-work approaches. Therefore, this framework should not be interpreted as a psychometric scale or a validated medico-legal instrument but rather as a clinically pragmatic tool intended to support proportionate reasoning and reduce variability in routine psychiatric work capacity evaluations across healthcare systems.